
In the current era of physician shortages, overbooked offices, antiquated fee schedules, and lengthy waiting lists for access to specialty care, the prospect of managing a patient with chronic kidney... Read More

In the current era of physician shortages, overbooked offices, antiquated fee schedules, and lengthy waiting lists for access to specialty care, the prospect of managing a patient with chronic kidney... Read More

Recommendation 1 in the BC guidelines for chronic kidney disease[1] published in 2004 lists the following high-risk groups: • Anyone with diabetes. • Anyone with hypertension with or without... Read More

Most of these patients have not been diagnosed in the past, in part because there has not been systematic screening of individuals we know are at higher risk of chronic kidney disease, including... Read More

A recent publication of the Therapeutics Initiative (TI) of British Columbia, “Do statins have a role in primary prevention?” suggested that statin medications (properly called HMG-CoA reductase... Read More

The guidelines that follow are proposed to support physicians in their clinical decisions related to the appropriate use of platelet products. They are not intended to provide a rigid prescription... Read More